Ab&B Bio-Tech CO., LTD. JS (HKG:2627)
Hong Kong · Delayed Price · Currency is HKD
40.30
+0.10 (0.25%)
Oct 31, 2025, 4:08 PM HKT
HKG:2627 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM | FY 2024 | FY 2023 |
|---|
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
|---|
| 108.43 | 132.19 | 45.32 |
| - | - | 22.24 |
| - | - | 10.02 |
Cash & Short-Term Investments | 108.43 | 132.19 | 77.57 |
| - | 70.41% | - |
| 148.17 | 284.91 | 73.6 |
| 15.29 | 20.49 | 14.77 |
| 163.46 | 305.4 | 88.37 |
| 107.74 | 57.81 | 41.82 |
| - | 0.14 | 5.49 |
| 379.63 | 495.54 | 213.25 |
Property, Plant & Equipment | 990.42 | 1,031 | 835.26 |
| 6.71 | 7.66 | 8.84 |
Long-Term Deferred Charges | 18 | 18 | 18 |
| 62.81 | 60.86 | 44.4 |
|
| 439.69 | 441.62 | 89.36 |
| - | - | 58.63 |
| 12.59 | 27.67 | - |
Current Portion of Long-Term Debt | 388.43 | 347.52 | 217.89 |
Current Portion of Leases | 4.46 | 7.15 | 6.47 |
Other Current Liabilities | 11.27 | 84.72 | 156.82 |
Total Current Liabilities | 859.88 | 908.68 | 529.16 |
| 506.78 | 462.01 | 148.26 |
| 4.23 | 42.13 | 48.81 |
Long-Term Unearned Revenue | 36.6 | 37.02 | 30.24 |
Other Long-Term Liabilities | 16.42 | 16.42 | - |
|
| 360 | 360 | 360 |
Additional Paid-In Capital | 712.32 | 691.37 | 614.93 |
| -1,091 | -969.08 | -710.36 |
Comprehensive Income & Other | 51.93 | 64.3 | 98.7 |
|
Total Liabilities & Equity | 1,458 | 1,613 | 1,120 |
| 916.49 | 886.48 | 421.42 |
| -808.07 | -754.29 | -343.85 |
| -2.24 | -2.10 | -0.96 |
Filing Date Shares Outstanding | 360 | 360 | 360 |
Total Common Shares Outstanding | 360 | 360 | 360 |
| -480.25 | -413.14 | -315.92 |
| 0.09 | 0.41 | 1.01 |
| 26.95 | 138.93 | 354.43 |
Tangible Book Value Per Share | 0.07 | 0.39 | 0.98 |
| - | 137.39 | 107 |
| - | 12.82 | 12.61 |
| - | 411.97 | 351.99 |
| - | 16.74 | 16.44 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.